Healthcare has long been perceived as a major growth area, and the Covid-19 pandemic has only heightened that trend, pushing the importance of health and wellbeing up the agenda for individuals and governments alike. Layer on technological developments that create the potential for major medical advances, as well as increasing the ability for consumers to monitor and service their own health and wellbeing needs, and it is clear the health megatrend has a long way left to go.
But for Tommy Erdei, global co-head and European head of healthcare investment banking at Jefferies, it is important not to lose sight of the fact that healthcare is a broad, diverse area spanning everything from large pharmaceutical companies to specialist biotech firms, diagnostics, services and IT. “Each segment has its own drivers, but overall they remain constructive,” he says.
